	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	C 2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	337	388	404	431	397	430	513	842	1,767	1,867	2,009	2,255	2,328	2,709	3,961
Cost of Operating Revenue	130	133	134	139	133	146	177	322	836	901	1,042	1,221	1,162	1,352	1,714
Gross Profit	207	255	270	292	264	285	336	520	931	965	968	1,034	1,166	1,357	2,247
Gross Margin	61.4	65.7	66.9	67.8	66.5	66.1	65.5	61.7	52.7	51.7	48.2	45.8	50.1	50.1	56.7
Total Operating Expenses	263	296	318	339	312	338	396	681	1,472	1,547	1,687	1,942	2,044	2,357	3,605
Operating Profit	74	92	85	92	84	92	116	161	295	319	322	313	284	352	356
Operating Margin	21.8	23.7	21.1	21.4	21.3	21.4	22.7	19.2	16.7	17.1	16.0	13.9	12.2	13.0	9.0
Financing Income/(Expense) - Net	9	16	18	27	31	32	32	9	-129	-75	-16	-12	-11	1	-91
Profit before Taxes	82	108	104	120	117	124	150	171	121	112	306	291	260	359	231
Income Taxes	14	9	5	9	12	13	13	-1	-20	-7	-3	-20	-7	12	33
Profit after Tax	68	97	96	109	103	109	134	169	142	119	309	310	267	347	197
PAT Margin	20.1	25.0	23.9	25.3	26.0	25.3	26.1	20.1	8.0	6.4	15.4	13.8	11.5	12.8	5.0
EPS - Basic - ex Extraordinary Items	3.46	4.97	4.94	5.58	5.29	5.58	6.85	8.02	4.92	3.91	9.71	9.76	8.39	10.90	6.20
EPS - Diluted - ex Extraordinary Items	3.46	4.97	4.94	5.58	5.29	5.58	6.85	8.02	4.92	3.91	9.71	9.76	8.39	10.90	6.20
EBIT	74	92	85	92	84	92	116	161	295	319	322	313	284	352	356
EBITDA	77	96	90	100	91	99	125	174	321	344	346	338	308	380	502
EBITDA Margin	23.0	24.9	22.3	23.2	23.0	23.0	24.4	20.6	18.2	18.4	17.2	15.0	13.2	14.0	12.7

Balance Sheet

Abridged

Understanding Balance Sheet

Zydus Wellness Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	2013 Mar 31	2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	167	241	303	385	433	516	647	698	776	847	814	908	1,214	1,104	1,367
Long-Term Investments	-	-	-	0	0	1	1	1	10	9	0	0	1	1	7
Property Plant & Equipment - Net	73	71	73	62	59	80	81	218	208	203	256	283	256	306	338
Total Non-Current Assets	101	108	121	123	135	167	182	4,761	4,814	4,820	4,878	4,925	4,934	5,338	8,941
Total Assets	267	349	425	508	568	683	829	5,459	5,590	5,666	5,692	5,833	6,148	6,442	10,308
Total Current Liabilities	74	85	89	62	75	113	122	546	615	771	767	692	769	746	729
Long Term Debt	-	-	-	-	-	-	-	1,500	1,501	313	67	3	3	1	3,047
Total Non-Current Liabilities	5	5	6	5	5	2	2	1,523	1,512	327	81	18	22	25	3,753
Total Liabilities	80	90	95	67	81	115	123	2,070	2,127	1,098	848	710	791	770	4,482
Total Shareholders' Equity	187	257	326	441	487	557	692	3,389	3,462	4,569	4,844	5,123	5,358	5,672	5,826
Minority Interest	1	3	5	-	-	11	13	-	-	-	-	-	-	-	-
Total Equity	188	259	330	441	487	568	706	3,389	3,462	4,569	4,844	5,123	5,358	5,672	5,826
Total Liabilities & Equity	267	349	425	508	568	683	829	5,459	5,590	5,666	5,692	5,833	6,148	6,442	10,308

Cash Flow

Abridged

Understanding Cash Flow Statement

Zydus Wellness Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	C 2013 Mar 31	2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	R 2020 Mar 31	C 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	74	107	101	117	108	123	146	100	148	258	320	319	278	396	352
Working Capital - Increase/(Decrease)	-3	-23	9	-21	12	-15	-48	40	-23	-66	-106	-240	-44	-27	-211
Net CF from Operating Activities	71	84	110	96	120	108	98	140	125	192	214	79	234	370	141
Capital Expenditures - Net	11	2	5	-3	4	31	8	17	25	17	75	44	26	65	101
Net CF from Investing Activities	-11	-2	-5	3	-58	-103	-90	-4,182	-22	-17	-68	-88	-30	-227	-2,911
Dividends Paid - Cash - Total	16	19	23	23	48	25	0	31	58	0	32	32	32	32	38
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	-	19	-	987	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-	-	-	-	-	25	-	1,544	-50	-970	-169	-91	30	-141	2,823
Net Cash Flow from Financing Activities	-18	-23	-27	-27	-58	-6	0	4,082	-120	-115	-201	-123	-2	-173	2,785
Free Cash Flow to Equity	60	82	104	99	117	102	90	1,667	50	-795	-31	-56	237	163	2,864
Free Operating CF net dividend	44	62	81	68	68	51	90	91	42	172	106	2	174	271	1
Free Operating CF	60	82	104	92	117	77	90	123	100	173	138	34	205	303	39

Business Segment Analysis

FY End:

Mar 25

Zydus Wellness Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Consumer Products. (100.0%)₹ 66.30 Cr

Revenue / Sales

Consumer Products. (100.0%)₹ 2,708.90 Cr

Assets

Consumer Products. (100.0%)₹ 6,441.90 Cr

Operating Income

Consumer Products. (100.0%)₹ 351.80 Cr

Regional Segment Analysis

Zydus Wellness Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Zydus Wellness Ltd.

Historical Segment Analysis

Track how Zydus Wellness Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31

Consumer Products.	25	20	75	45	29	66

Frequently Asked Questions

What is the revenue of Zydus Wellness Ltd.?

The latest trailing twelve month revenue of Zydus Wellness Ltd. is ₹ 3,961.00 Cr, reflecting a 1-year growth of 46.22% and a 3-year CAGR of 20.66%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Zydus Wellness Ltd.?

The latest trailing twelve month net profit (PAT) of Zydus Wellness Ltd. is ₹ 197.20 Cr, with a 3-year earnings CAGR of -14.02%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Zydus Wellness Ltd.?

The trailing twelve month EBITDA of Zydus Wellness Ltd. is approximately ₹ 355.60 Cr (based on an operating margin of 8.98%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Zydus Wellness Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Zydus Wellness Ltd. is 6.20. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Zydus Wellness Ltd.?

The debt-to-equity ratio of Zydus Wellness Ltd. stands at 0.55. The interest coverage ratio is 3.62x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Zydus Wellness Ltd.?

The estimated book value per share of Zydus Wellness Ltd. is 184.30 (derived from a P/B ratio of 3.25 and market price of ₹ 598.30), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Zydus Wellness Ltd.?

The trailing twelve month operating cash flow of Zydus Wellness Ltd. is ₹ 141.00 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Zydus Wellness Ltd. report consolidated or standalone financials?

Zydus Wellness Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.